Related Experiment Videos
[The use of nebivolol in menopausal women with hypertension]
N P Alekseeva1, E V Belova, V G Larin
1Cardiology Center for South-Western Administrative Region of Moscow, Russia.
Abstract:
Nebivolol was given for 8 weeks to 34 menopausal women with grade 1 and 2 hypertension. Monotherapy was effective in 66,7% of patients, while in other patients combination with hydrochlorothiazide (12.5 mg) was required. The use of nebivolol was associated with decreased rate and severity of vasomotion reactions and thus with positive effect on menopausal syndrome. Nebivolol appeared to be safe and metabolically neutral.
Related Concept Videos
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Heart Failure Drugs: β-Blockers
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Types of β-Blockers
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...